Nanotechnology For HIV: New Technique Shows Promising Results In HIV Treatment
Nanotechnology has long been regarded as the manipulation of matter on an atomic, molecular, and supramolecular scale, and can be applied in the medical field as nanomedicine. That being said, a new study conducted by the University of Liverpool researchers suggest that the use of nanotechnology in medicine may significantly improve drug therapies for HIV patients. The study's authors have explained that this evolving discipline has the potential to significantly improve HIV treatment and pave the way for new techniques.
Nanotechnology For HIV
According to reports revealed by Controlled Environments, as of the press time, the treatment of HIV intensively requires a daily oral dosing of HIV drugs, and, in turn, chronic oral dosing has allegedly created significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have greatly shown a huge level of willingness to switch to nanomedicine alternatives provided that benefits can be shown. It was found that the research has been focused on the development of new oral therapies suggests that using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reduces both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.
Furthermore, as reported by Science Daily, the trial results served as an affirmation of the potential for a 50 percent dose reduction while maintaining therapeutic exposure, using a novel approach to formulation of two drugs namely efavirenz (EFV) and, lopinavir (LPV). Consequently, the researchers said that the trial involved in the study is apparently connected to the University's ongoing work as part of the multinational consortium OPTIMIZE, which is said to be a global partnership working to accelerate access to simpler, safer and more affordable HIV treatment. Subsequently, OPTIMIZE is led by the Wits Reproductive Health & HIV Institute in Johannesburg, South Africa, and includes the interdisciplinary Liverpool team, Columbia University, Mylan Laboratories and the Medicines Patent Pool (MPP) and is being supported by key partners including UNITAID and the South African Medical Research Council (SAMRC).
Meanwhile, Benny Kottiri, USAID's Office of HIV/AIDS Research Division Chief has claimed that the potential applications for HIV treatment are incredibly promising. He explains that by aligning efforts, these integrated investments offer the potential to reduce the doses required to control the HIV virus even further, resulting in real benefits globally. Ultimately, experts believe that the idea would enable the costs of therapy to be reduced; something that is particularly beneficial for resource-limited countries where the burden of disease is highest.
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
PrEP For HIV: Raising Awareness; Could It Be The Cure For The Disease?
Considering that HIV has been and is still currently is one of the world’s most dreaded diseases, how essential is the use of PrEP? Could it possibly hold the key for cure that a lot of people have been waiting for? What’s the truth behind claims these claims? Find out what health professionals have to say
HIV Update: The 'HIV Conserv’ Vaccine And Its Promising Results
Considering the continuous efforts to eradicate the global health problem brought by HIV, what's the truth behind claims of a researcher about the so-called 'kick and kill' strategy by being a potential key for the long dreaded disease? How effective is this trial and what are the chances of being cured from the disease? Find out what experts have to say
MORE IN ITECHPOST
iOS 11 Plagued with Untested Bugs and Early Adoption Pitfalls
Reports of nagging iOS 11 issues have started pouring in just a day after the software was released by Apple on supported devices.
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
‘Resident Evil 7: Not A Hero DLC’ First Gameplay Trailer Leaks Online
First gameplay trailer pertaining to RE7: Not A Hero DLC has just leaked on YouTube.